ALSUntangled does not recommend hyperbaric oxygen therapy for ALS
Original source
Hyperbaric Oxygen (opens in a new tab)ALSUntangled reviewed hyperbaric oxygen therapy (HBOT) for amyotrophic lateral sclerosis (ALS) and said the best available human trial found no benefit. The group also noted that HBOT can cause potentially serious complications and does not believe one reported ALS reversal was caused by HBOT alone.
Why this matters
This means ALSUntangled does not recommend HBOT for people with ALS at this time. The review does not provide evidence that HBOT improves ALS, so it should not be considered an established treatment based on this report.
Limitations and context
This is an independent expert review published in 2016, not a new clinical trial. The source does not provide details of the human trial in the supplied material. ALSUntangled states that it is sponsored by the ALS Association and the Motor Neurone Disease Association. The review discusses a single reported reversal alongside several alternative treatments, so it cannot establish that HBOT caused the outcome.